United Therapeutics Chairperson and CEO Martine A. Rothblatt reports $5.59 million common-share sale
Bitget2026/10/27 20:48- United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on Oct. 26, 2026.
- Sales were reported at weighted-average prices ranging from $585.7122 to $592.9168 per share.
- Rothblatt also exercised stock options for 9,500 common shares at $117.76 per share.
- The transactions left 324,443 common shares held indirectly through trusts involved in the trades; direct holdings totaled 40,513 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley: AI capital expenditure may reach 10 to 15 trillions USD in the next 10 years
Morgan Stanley stated that capital expenditure in the artificial intelligence (AI) sector could reach $10-15 trillions over the next decade.
Morgan Stanley: Apple's target price lowered to $350
Autoliv completes acquisition of MCF Safety Belts
Refining profits surge and oil prices soar; Saudi Aramco Q3 profits grow by 9% and maintains a dividend of 21.9 billions USD.
Driven by rising refining profits and oil prices, Saudi Aramco's third-quarter profits increased by 9%.
Crypto prices
More
